These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 19826051)

  • 21. Hypoxia induces escape from innate immunity in cancer cells via increased expression of ADAM10: role of nitric oxide.
    Barsoum IB; Hamilton TK; Li X; Cotechini T; Miles EA; Siemens DR; Graham CH
    Cancer Res; 2011 Dec; 71(24):7433-41. PubMed ID: 22006996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30.
    Schlecker E; Fiegler N; Arnold A; Altevogt P; Rose-John S; Moldenhauer G; Sucker A; Paschen A; von Strandmann EP; Textor S; Cerwenka A
    Cancer Res; 2014 Jul; 74(13):3429-40. PubMed ID: 24780758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.
    Doberstein K; Pfeilschifter J; Gutwein P
    Carcinogenesis; 2011 Nov; 32(11):1713-23. PubMed ID: 21880579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ADAM10 is the constitutive functional sheddase of CD44 in human melanoma cells.
    Anderegg U; Eichenberg T; Parthaune T; Haiduk C; Saalbach A; Milkova L; Ludwig A; Grosche J; Averbeck M; Gebhardt C; Voelcker V; Sleeman JP; Simon JC
    J Invest Dermatol; 2009 Jun; 129(6):1471-82. PubMed ID: 18971959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma.
    Armeanu S; Krusch M; Baltz KM; Weiss TS; Smirnow I; Steinle A; Lauer UM; Bitzer M; Salih HR
    Clin Cancer Res; 2008 Jun; 14(11):3520-8. PubMed ID: 18519785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma.
    Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J
    Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma.
    Liu Y; Zhang W; Liu S; Liu K; Ji B; Wang Y
    Oncol Rep; 2017 Mar; 37(3):1857-1864. PubMed ID: 28184920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
    Liu S; Zhang W; Liu K; Ji B; Wang G
    Mol Med Rep; 2015 Jan; 11(1):597-602. PubMed ID: 25323956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cells.
    Arai J; Goto K; Tanoue Y; Ito S; Muroyama R; Matsubara Y; Nakagawa R; Kaise Y; Lim LA; Yoshida H; Kato N
    Int J Cancer; 2018 Nov; 143(10):2575-2583. PubMed ID: 29873070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of ADAM10 and ADAM17 in CD16b shedding mediated by different stimulators.
    Guo S; Peng M; Zhao Q; Zhang W
    Chin Med Sci J; 2012 Jun; 27(2):73-9. PubMed ID: 22770404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10.
    Parkin E; Harris B
    J Neurochem; 2009 Mar; 108(6):1464-79. PubMed ID: 19183255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
    Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
    Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A soluble form of the giant cadherin Fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain shedding.
    Wojtalewicz N; Sadeqzadeh E; Weiß JV; Tehrani MM; Klein-Scory S; Hahn S; Schmiegel W; Warnken U; Schnölzer M; de Bock CE; Thorne RF; Schwarte-Waldhoff I
    PLoS One; 2014; 9(3):e90461. PubMed ID: 24625754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: novel drug targets with therapeutic potential?
    Saftig P; Reiss K
    Eur J Cell Biol; 2011; 90(6-7):527-35. PubMed ID: 21194787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metallopeptidase 2 (MMP2) mediates MHC class I polypeptide-related sequence A (MICA) shedding in renal cell carcinoma.
    Yang FQ; Liu M; Yang FP; Zhang XL; Yang B; Guo CC; Huang JH; Che JP; Yan Y; Zheng JH
    Actas Urol Esp; 2014 Apr; 38(3):172-8. PubMed ID: 24461475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.
    Lee SB; Schramme A; Doberstein K; Dummer R; Abdel-Bakky MS; Keller S; Altevogt P; Oh ST; Reichrath J; Oxmann D; Pfeilschifter J; Mihic-Probst D; Gutwein P
    J Invest Dermatol; 2010 Mar; 130(3):763-73. PubMed ID: 19865098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts.
    Mezyk-Kopeć R; Bzowska M; Stalińska K; Chełmicki T; Podkalicki M; Jucha J; Kowalczyk K; Mak P; Bereta J
    Cytokine; 2009 Jun; 46(3):309-15. PubMed ID: 19346138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinoids Decrease Soluble MICA Concentration by Inhibiting the Enzymatic Activity of ADAM9 and ADAM10.
    Otoyama Y; Arai J; Goto K; Nozawa H; Nakagawa R; Muroyama R; Sugiura I; Nakajima Y; Kajiwara A; Tojo M; Ichikawa Y; Uozumi S; Shimozuma Y; Uchikoshi M; Sakaki M; Kato N; Yoshida H
    Anticancer Res; 2021 May; 41(5):2307-2320. PubMed ID: 33952456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10.
    Schelter F; Grandl M; Seubert B; Schaten S; Hauser S; Gerg M; Boccaccio C; Comoglio P; Krüger A
    Clin Exp Metastasis; 2011 Dec; 28(8):793-802. PubMed ID: 21789719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADAM10 is the major sheddase responsible for the release of membrane-associated meprin A.
    Herzog C; Haun RS; Ludwig A; Shah SV; Kaushal GP
    J Biol Chem; 2014 May; 289(19):13308-22. PubMed ID: 24662289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.